KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Change in Acquisitions & Divestments (2018 - 2025)

Historic Change in Acquisitions & Divestments for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $50.9 million.

  • Adaptive Biotechnologies' Change in Acquisitions & Divestments fell 2613.88% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.5 million, marking a year-over-year decrease of 3496.98%. This contributed to the annual value of $325.7 million for FY2024, which is 4284.75% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Change in Acquisitions & Divestments stood at $50.9 million for Q3 2025, which was down 2613.88% from $55.1 million recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Change in Acquisitions & Divestments peaked at $155.0 million during Q4 2021, and registered a low of $35.0 million during Q2 2022.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $99.5 million (2024), whereas its average is $101.9 million.
  • In the last 5 years, Adaptive Biotechnologies' Change in Acquisitions & Divestments plummeted by 7577.85% in 2022 and then soared by 30114.86% in 2023.
  • Over the past 5 years, Adaptive Biotechnologies' Change in Acquisitions & Divestments (Quarter) stood at $155.0 million in 2021, then crashed by 54.82% to $70.0 million in 2022, then skyrocketed by 80.63% to $126.5 million in 2023, then crashed by 47.04% to $67.0 million in 2024, then decreased by 24.05% to $50.9 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $50.9 million for Q3 2025, versus $55.1 million for Q2 2025 and $77.5 million for Q1 2025.